A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice https://www.biorxiv.org/content/10.1101/2023.05.05.539395v1?med=mas
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice https://www.biorxiv.org/content/10.1101/2023.05.05.539395v1?med=mas